Global Pharma Headlines: Potential Alzheimer’s Breakthrough and Strategic Acquisitions
Published on: July 29, 2025, 10:29 a.m. | Source: Devdiscourse
Emerging news in the health sector highlights Roche's potential Alzheimer's breakthrough with Trontinemab, UnitedHealth's investor scrutiny on elevated costs under CEO Stephen Hemsley, Celltrion's bid to mitigate U.S. tariffs with a factory acquisition, Nordic Capital's $3 billion offer for Bavarian Nordic, and Novo Nordisk's strategic growth plans for Wegovy.
